摘要:
Aminated isoflavonoid synthesized by aminating the 4-keto group of isoflavanone and isoflavanone ring systems, pharmaceutical compositions containing same and uses thereof as therapeutic agents.
摘要:
Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors. This is exemplified.
摘要:
Isoflavone compounds of the formula (I) or (II) Where R can be R7? or OR7? or O and the formula (III) is either a single or double bond extends to Y then Y is an optionally substituted benzyl. W, R1?, Zo? R2? and R7? are as defined in the specification. The compounds are useful for the treatment of certain diseases and disorders, including cancer and inflammation.
摘要翻译:式(I)或(II)的异黄酮化合物其中R可以是R 7? 或OR 7? 或O,式(III)是单键或双键延伸至Y,则Y为任选取代的苄基。 W,R 1 ?, Z o? R 2? 和R 7? 如说明书中所定义。 该化合物可用于治疗某些疾病和病症,包括癌症和炎症。
摘要:
Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
摘要:
Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
摘要:
The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents.
摘要:
Novel chroman derivatives and intermediate compounds, compositions containing same, methods for their preparation and uses thereof as therapeutic agents particularly as anti-cancer and chemotherapeutic selective agents are described.
摘要:
Methods for the hydrogenation of isoflavones are described which provide access to workable quantities of isoflavan-4-ols, isoflav-3-enes, and isoflavans. The isoflavone derivatives can be obtained in high purity and in near quantitative yields whilst employing pharmaceutically acceptable reagents and solvents.